3-Bromo-5-benzofurancarboxylic acid

3-Bromo-5-benzofurancarboxylic acid (CAS 501892-83-7) is a pharmaceutical-grade intermediate supplied by Shanghai Rlavie Technology Co.,ltd. It is manufactured in-house rather than sourced from a third party, with sales across major global markets such as North America, Central/South America, Europe, among others. It is produced to recognized quality standards such as the Chinese Pharmacopoeia (ChP), USP, the British Pharmacopoeia (BP), the European Pharmacopoeia (EP), the Japanese Pharmacopoeia (JP), the International Pharmacopoeia (Ph. Int), the Indian Pharmacopoeia (IP). Per the supplier's listing, it is assayed at a minimum of 98% purity.